Simultaneous drug-eluting and bare-metal stent implantation: Long-term clinical outcome and findings of clinically indicated coronary angiography

Clinical Cardiology

Volumn 34, Issue 5, 2011, Pages 317-321

  Alexopoulos, Dimitrios ^a   Xanthopoulou, Ioanna ^a   Karantalis, Vasileios ^a   Mitropoulou, Georgia ^a   Damelou, Anastasia ^a   Davlouros, Periklis ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROGNOSIS; RESTENOSIS; STABLE ANGINA PECTORIS; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; STATISTICS AS TOPIC; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955906896     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20878     Document Type: Article

References (8)

1. Schampaert E, Moses JW, Schofer J, et al. for the SIRIUS, E-SIRIUS, and C-SIRIUS Investigators. Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses. Am J Cardiol. 2006; 98: 36-41. (Pubitemid 43902677)
2. Mauri L, Silbaugh T, Wolf R, et al. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation. 2008; 118: 1817-1827.
3. Chu W, Rha SW, Kuchulakanti P, et al. Selective versus exclusive use of sirolimus-eluting stent implantation in multivessel coronary artery disease. Catheter Cardiovasc Interv. 2005; 65: 473-477. (Pubitemid 41060747)
4. Bertrand O, Faurie B, Larose E, et al. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents. J Invasive Cardiol. 2008; 20: 99-104. (Pubitemid 351346280)
5. Fineschi M, Gori T, Pierli C, et al. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolomus-eluting stents in the real world. Can J Cardiol. 2005; 21: 1281-1285. (Pubitemid 43174609)
6. Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1988; 78; 486-502.
7. Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007; 356: 1009-1019. (Pubitemid 46376801)
8. Mirabella F, Francaviglia B, Capodanno D, et al. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results. J Invasive Cardiol. 2009; 21: 145-150.